Drägerwerk AG & Co. KGaA (ETR:DRW8)

Germany flag Germany · Delayed Price · Currency is EUR
73.40
+0.80 (1.10%)
May 25, 2026, 5:35 PM CET
Market Cap1.53B +48.6%
Revenue (ttm)3.51B +4.2%
Net Income153.02M +32.8%
EPSn/a
Shares Outn/a
PE Ratio10.01
Forward PE10.35
Dividend2.21 (3.10%)
Ex-Dividend DateMay 11, 2026
Volume1,599
Average Volume2,326
Open72.40
Previous Close72.60
Day's Range72.40 - 75.60
52-Week Range50.00 - 77.40
Beta0.56
RSI56.96
Earnings DateApr 30, 2026

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]

Sector Healthcare
Founded 1889
Employees 16,033
Stock Exchange Deutsche Börse Xetra
Ticker Symbol DRW8

Financial Performance

In 2025, Drägerwerk AG & Co. KGaA's revenue was 3.48 billion, an increase of 3.29% compared to the previous year's 3.37 billion. Earnings were 139.50 million, an increase of 12.13%.

Financial Statements

News

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q1 2026

EBIT and Free Cash Flow rose sharply in Q1 2026, with strong sales growth and improved margins. Both divisions contributed to higher earnings, and guidance for the year remains positive, with no material impact expected from tariffs or geopolitical risks.

25 days ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: Investor presentation

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Quarterly report: Q1 2026

Drägerwerk AG & Co. KGaA has published its Q1 2026 quarterly earnings report on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q1 2026

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Earnings release: Q1 2026

Drägerwerk AG & Co. KGaA released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q1 2026

EBIT and Free Cash Flow rose sharply in Q1 2026, with strong sales growth and improved margins. Both divisions contributed to higher earnings, and guidance for the year remains positive, with no material impact expected from tariffs or geopolitical risks.

25 days ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: Investor presentation

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Quarterly report: Q1 2026

Drägerwerk AG & Co. KGaA has published its Q1 2026 quarterly earnings report on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q1 2026

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Earnings release: Q1 2026

Drägerwerk AG & Co. KGaA released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q1 2026

EBIT and Free Cash Flow rose sharply in Q1 2026, with strong sales growth and improved margins. Both divisions contributed to higher earnings, and guidance for the year remains positive, with no material impact expected from tariffs or geopolitical risks.

25 days ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: Investor presentation

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Quarterly report: Q1 2026

Drägerwerk AG & Co. KGaA has published its Q1 2026 quarterly earnings report on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q1 2026

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Earnings release: Q1 2026

Drägerwerk AG & Co. KGaA released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.

25 days ago - Filings

Drägerwerk AG & Co. KGaA Transcript: German Select VII Conference

The company reported record sales and margin growth in 2025, driven by strong operational performance and innovation in open medical ecosystems. Defense and Safety segments are set for significant expansion, while margin improvement will rely on top-line growth, pricing, and cost control.

5 weeks ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: German Select VII Conference

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.

5 weeks ago - Filings

Drägerwerk AG & Co. KGaA Transcript: German Select VII Conference

The company reported record sales and margin growth in 2025, driven by strong operational performance and innovation in open medical ecosystems. Defense and Safety segments are set for significant expansion, while margin improvement will rely on top-line growth, pricing, and cost control.

5 weeks ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: German Select VII Conference

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.

5 weeks ago - Filings

Drägerwerk AG & Co. KGaA Transcript: German Select VII Conference

The company reported record sales and margin growth in 2025, driven by strong operational performance and innovation in open medical ecosystems. Defense and Safety segments are set for significant expansion, while margin improvement will rely on top-line growth, pricing, and cost control.

5 weeks ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: German Select VII Conference

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.

5 weeks ago - Filings

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q4 2025

Record net sales and EBIT were achieved in 2025, with both divisions and all regions contributing to growth. Despite significant tariff and currency headwinds, profitability improved, and strong cash flow supported higher dividends and reduced debt.

2 months ago - Transcripts

Drägerwerk AG & Co. KGaA Annual report: Q4 2025

Drägerwerk AG & Co. KGaA has published its Q4 2025 annual report on March 24, 2026.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Earnings release: Q4 2025

Drägerwerk AG & Co. KGaA released its Q4 2025 earnings on March 24, 2026, summarizing the period's financial results.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Annual report: Q4 2025

Drägerwerk AG & Co. KGaA has published its Q4 2025 annual report on March 24, 2026.

2 months ago - Filings